Impact of Sampling Paper/Cards on Bioanalytical Quantitation via Dried Blood Spots by Liquid Chromatography-Mass Spectrometry

  • Jun ZhangEmail author
  • Ramona Rodila
  • Huaiqin Wu
  • Tawakol A. El-Shourbagy


Dried blood spots (DBS) on paper as a sampling technique in newborn screening has been widely adopted by bioanalytical chemists for preclinical and clinical sample collection. DBS is based on the assumption that single size punch of DBS absorbs the same volume of blood regardless of physiological differences derived from test subject genders, disease states, nutrition, or hydration affecting blood viscosity, although it is well known that such differences have a fundamental impact on the quantitation accuracy of DBS as a sampling technique. There are multiple types of sampling media in either plain filter paper or chemically treated paper/cards available for DBS applications. Pretreated paper/cards contain chemicals such as denaturants, surfactants, and/or chelating agents to deactivate pathogens, enzymes and prevent the growth of biological organisms. In this chapter, the chemical constituents of various paper/cards are explored. The impact of paper/card type on analytical interference, evenness of DBS spots, and radial distribution of analyte are evaluated. The paper/card impact on the matrix effect was studied. It was found that the impregnated chemicals on the pretreated DBS paper/cards could be more than 50 % of the total paper/card weight. These water-soluble chemicals make the analyte distribution unpredictable across the dried blood spots and can interfere with LC-MS. Six compounds across a large Log D range were used to evaluate different types of paper/cards for understanding the impact of the sampling paper/cards on DBS quantitation accuracy. The results indicate that the impact is significant and an evaluation of sampling paper/card impact is necessary for most compounds.


Matrix Effect Newborn Screening Fresh Human Blood Analyte Distribution Size Punch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Guthrie R, Suzi A (1963) Pediatrics 32:338Google Scholar
  2. 2.
    Parker SP, Cubit WD (1999) J Clin Pathol 52:633CrossRefGoogle Scholar
  3. 3.
    Gamlen TR, James HC, Batstone GF (1982) Scand J Clin Lab Invest 42:643CrossRefGoogle Scholar
  4. 4.
    Mei JV, Alexander JR, Adam BW, Hannon WH (2001) J Nutr 131:1631SGoogle Scholar
  5. 5.
    Li W, Tse LF (2010) Biomed Chromatogr 24:49CrossRefGoogle Scholar
  6. 6.
    Coombes EJ, Gamlen TR, Batstone GF, Leigh PN (1984) Ann Clin Biochem 21:519Google Scholar
  7. 7.
    Coombes EJ, Gamlen TR, Batstone GF, Holgate ST (1984) Clin Chim Acta 136:187CrossRefGoogle Scholar
  8. 8.
    Lindström B, Ericsson Ő, Alva´n G, Rombo L, Ekman L, Rais M, Sjöqvist F (1985) Ther Drug Monit 7:207CrossRefGoogle Scholar
  9. 9.
    Hibberd SG, Alveyn C, Coombes EJ, Holgate ST (1986) Br J Clin Pharmacol 22:337CrossRefGoogle Scholar
  10. 10.
    Fujimoto T, Tawa R, Hirose S (1988) Chem Pharm Bull 36:1571CrossRefGoogle Scholar
  11. 11.
    Bergqvist Y, Al Kabbani J, Krysén B, Berggren Palme I, Rombo L (1993) J Chromatogr 615:297CrossRefGoogle Scholar
  12. 12.
    Ericsson Ő, Fridén M, Hellgren U, Gustafsson LL (1993) Ther Drug Monit 15:334CrossRefGoogle Scholar
  13. 13.
    Bergqvist Y, Doverskog M, Al Kabbani J (1994) J Chromatogr B 652:73CrossRefGoogle Scholar
  14. 14.
    Rønn AM, Lemnge MM, Angelo HR, Bygbjerg IC (1995) Ther Drug Monit 17:79CrossRefGoogle Scholar
  15. 15.
    Bergqvist Y, Funding L, Kaneko A, Krysén B, Leek T (1998) J Chromatogr B 719:141CrossRefGoogle Scholar
  16. 16.
    Craft NE, Haitema T, Brindle LK, Yamini S, Humphrey JH, West KP Jr (2000) J Nutr 130:882Google Scholar
  17. 17.
    Lindegårdh N, Funding L, Bergqvist Y (2001) J Chromatogr B 758:137CrossRefGoogle Scholar
  18. 18.
    Green MD, Mount DL, Nettey H (2002) J Chromatogr B 767:159CrossRefGoogle Scholar
  19. 19.
    Oliveira EJ, Watson DG, Morton NS (2002) J Pharm Biomed Anal 29:803CrossRefGoogle Scholar
  20. 20.
    Malm M, Lindegårdh N, Bergqvist Y (2004) J Chromatogr B 809:43CrossRefGoogle Scholar
  21. 21.
    Minzi OMS, Massele AY, Gustafsson LL, Ericsson Ð (2005) J Chromatogr B 814:179CrossRefGoogle Scholar
  22. 22.
    Koal T, Burhenne H, Romline R, Svoboda M, Resch K, Kaever V (2005) Rapid Commun Mass Spectrom 19:2995CrossRefGoogle Scholar
  23. 23.
    AbuRuz S, Millership J, McElnay J (2006) J Chromatogr B 832:202CrossRefGoogle Scholar
  24. 24.
    Allanson AL, Cotton MM, Tettey JNA, Boyter AC (2007) J Pharm Biomed Anal 44:963CrossRefGoogle Scholar
  25. 25.
    Blessborn D, Romsing S, Annerberg A, Sundquist D, Bjorkman A, Lindegardh N, Bergqvist Y (2007) J Pharm Biomed Anal 45:282CrossRefGoogle Scholar
  26. 26.
    Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP, Stolk LML (2007) J Pharm Biomed Anal 44:658CrossRefGoogle Scholar
  27. 27.
    Kolawole JA, Taylor RB, Moody RR (1995) J Chromatogr B 674:149CrossRefGoogle Scholar
  28. 28.
    Lejeune D, Souletie I, Houze S, Le bricon T, Le bras T, Gourmet B, Houze P (2007) J Pharm Biomed Anal 43:1106CrossRefGoogle Scholar
  29. 29.
    Ntale M, Mahindi M, Ogwal-Okeng JW, Gustafsson LL, Beck O (2007) J Chromatogr B 859:137CrossRefGoogle Scholar
  30. 30.
    Barfield M, Spooner N, Lad R, Parry S, Fowles S (2008) J Chromatogr B 870:32CrossRefGoogle Scholar
  31. 31.
    Sosnoff CS, Bernert JT (2008) Clin Chim Acta 388:228CrossRefGoogle Scholar
  32. 32.
    ter Heine R, Rosing H, van Gorp ECM, Mulder JW, van der Steeg WA, Beijnen JH, Huitema ADR (2008) J Chromatogr B 867:205CrossRefGoogle Scholar
  33. 33.
    Liang X, Li Y, Barfied M, Ji QC (2009) J Chromatogr B 877:799CrossRefGoogle Scholar
  34. 34.
    Higashia T, Nishioa T, Uchida S, Shimada K, Fukushib M, Maedac M (2008) J Pharm Biomed Anal 4(8):177CrossRefGoogle Scholar
  35. 35.
    Spooner N, Lad R, Barfield M (2009) Anal Chem 81:1557CrossRefGoogle Scholar
  36. 36.
    van der Heijden J, de Beer Y, Hoogtanders K, Christiaans M, de Jong GJ, Neef C, Stolk L (2009) J Pharm Biomed Anal 50:664CrossRefGoogle Scholar
  37. 37.
    Denniff P, Spooner N (2010) Bioanalysis 2:1385CrossRefGoogle Scholar
  38. 38.
    Burgoyne LA. US Patent 5,496,562 (1996); 5,756,126 (1998) and 5,807,127 (1998).Google Scholar
  39. 39.
    Gao L, Cheng X, Zhang J, Burns DJ (2007) Rapid Commun Mass Spectrom 21:3497CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Jun Zhang
    • 1
    Email author
  • Ramona Rodila
    • 1
  • Huaiqin Wu
    • 1
  • Tawakol A. El-Shourbagy
    • 1
  1. 1.Global Pharmaceutical Research and DevelopmentAbbott LaboratoriesAbbott ParkUSA

Personalised recommendations